Immunotherapy for cancer: the use of lymphokine activated killer (LAK) cells.

類似資料

• Lymphokine activated killer (LAK) cells in patients with gastrointestinal cancer.
  著者:: Monson, J R, 等
  出版事項: (1987)
• Release of cytokines during generation of lymphokine-activated killer (LAK) cells by IL-2.
  著者:: Limb, G A, 等
  出版事項: (1989)
• Natural cytotoxicity in the neonate: high levels of lymphokine activated killer (LAK) activity.
  著者:: Montagna, D, 等
  出版事項: (1988)
• Generation of adherent lymphokine activated killer (A-LAK) cells from patients with acute myelogenous leukaemia.
  著者:: Sedlmayr, P., 等
  出版事項: (1992)
• Increased lymphokine activated killer (LAK) activity in the regional lymph nodes of mice following immunization with contact sensitizing agents.
  著者:: Gao, L Q, 等
  出版事項: (1987)